Benefits for Intra-, Extracapsular Tonsillectomy in Peds OSA

This article originally appeared here.
Share this content:
Benefits for Intra-, Extracapsular Tonsillectomy in Peds OSA
Benefits for Intra-, Extracapsular Tonsillectomy in Peds OSA

WEDNESDAY, Dec. 2, 2015 (HealthDay News) -- For children with obstructive sleep apnea syndrome (OSAS), both extracapsular tonsillectomy and adenoidectomy (ETA) and intracapsular tonsillectomy and adenoidectomy (ITA) are effective, according to a study published online Nov. 19 in JAMA Otolaryngology-Head & Neck Surgery.

Pamela Mukhatiyar, M.D., from the Albert Einstein College of Medicine in Bronx, N.Y., and colleagues conducted a retrospective cohort study using medical records from 89 children who underwent ETA or ITA. Patients had no evidence of craniofacial or neurological disorders.

The researchers found that 52 children underwent ETA and 37 underwent ITA. Children in the ETA group were older (P = 0.001) and more obese (P = 0.004) than those in the ITA group. OSAS severity was similar between the groups, with median preoperative obstructive apnea-hypopnea indexes of 17.0 and 24.1 in the ETA and ITA groups, respectively (P = 0.21), and similar prevalences of asthma (38 percent in each group). Significant improvement was seen on polysomnography in both groups after surgery, with no between-group differences in clinical outcomes. No correlation was seen for procedure type, age, or body mass index z score with treatment failure; however, ITA correlated with residual OSAS in a subset of patients with asthma and obesity (odds ratio, 16.5; P = 0.04).

"Both ETA and ITA are effective modalities to treat OSAS, with comparable surgical outcomes on short-term follow-up," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »